1-(3-Bromopyridin-2-yl)piperazine hydrochloride, 10g

5-(3-Chloro-5-methylphenyl)oxazole, 98%, 500mg

1-[2-[(tert-Butoxycarbonyl)amino]ethyl]-1H-indole-6-carboxylic acid, 97.0%, 1g

5-Pyridin-2-yl-2H-pyrazol-3-ylamine, 95.0%, 250mg

6-((5-((6-Chlorohexyl)oxy)pentyl)oxy)hexanoic acid, 97%, 100mg

(2E)-3-(2-chlorophenyl)-1-(2,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

2-(4-Chloro-phenylamino)-5-methyl-thiazole-4-carboxylic acid ethyl ester, 95.0%, 1g

Hydroxypropyl Acrylate (mixture of 2-Hydroxypropyl and 2-Hydroxy-1-methylethyl Acrylate) (stabilized with MEHQ)>90.0%(GC)500mL

1,2,4-Trifluoro-3-iodobenzene, 95.0%, 1g

1-Bromo-2-fluoro-4-methoxy-3-nitrobenzene, 95.0%, 5g

1,1,2,2-Tetrafluoroethyl-2,2,3,3-tetrafluoropropyl ether, 98.0%, 1g

4-Aminobicyclo[2.2.2]octane-1-carbonitrile hydrochloride, 95.0%, 250mg

2-(TERT-BUTOXYCARBONYL)-2-AZABICYCLO[2.1.1]HEXANE-4-CARBOXYLIC ACID, 95.0%, 250mg